What is Dataplus Pharma Services?
Dataplus Pharma Services operates as a specialized clinical data services organization, providing essential support to the pharmaceutical, biotechnology, and medical device industries. The company's core competencies include clinical data management, biostatistics, and the implementation of rigorous data standards. By facilitating electronic submissions and providing comprehensive statistical analysis, Dataplus acts as a vital partner in the clinical trial lifecycle. Their dual-pronged approach, which combines expert consultancy with proprietary software development, allows them to address complex data challenges across various therapeutic areas, ensuring compliance and efficiency from early-phase research through to late-stage clinical development.
How much funding has Dataplus Pharma Services raised?
Dataplus Pharma Services has raised a total of $315K across 1 funding round:
Debt
$315K
Debt (2021): $315K with participation from PPP
Key Investors in Dataplus Pharma Services
PPP
Public-Private Partnership
What's next for Dataplus Pharma Services?
With the successful acquisition of $315K, Dataplus Pharma Services is entering a pivotal growth phase. The company is expected to utilize this capital to scale its software development initiatives and expand its footprint in global clinical operations. As the demand for high-fidelity data management in drug development continues to rise, Dataplus is well-positioned to capture additional market share. Future strategic efforts will likely focus on enhancing their electronic submission platforms and deepening their biostatistical expertise to meet the evolving regulatory requirements of the global life sciences market.
See full Dataplus Pharma Services company page
